Probiotic formulation development focuses on creating effective, safe, and stable probiotic products. This process involves selecting specific strains of beneficial bacteria that can survive in the gastrointestinal tract and confer health benefits, such as improved digestion and enhanced immune function. Key considerations in formulation include choosing appropriate probiotic strains, optimizing their viability during storage and delivery, and combining them with prebiotics—substances that nourish and support the growth of probiotics. The formulation must also account for factors like taste, texture, and shelf life to ensure consumer acceptance. Advanced techniques in encapsulation and microencapsulation are often employed to protect probiotics from environmental stresses and improve their efficacy. Rigorous testing for stability, potency, and safety is essential to ensure the final product meets quality standards and delivers the intended health benefits.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India